Pharmacogenetics in the Treatment of Pre-Eclampsia: Current Findings, Challenges and Perspectives
Pre-eclampsia (PE) is defined as pregnancy-induced hypertension and proteinuria, and is a major cause of maternal and perinatal morbidity and mortality. A large subgroup of pregnant women with PE is nonresponsive to antihypertensive drugs, including methyldopa, nifedipine and hydralazine. Pharmacoge...
Збережено в:
| Автори: | , , , |
|---|---|
| Формат: | Revisão |
| Мова: | Англійська |
| Опубліковано: |
2017
|
| Онлайн доступ: | https://doi.org/10.2217/pgs-2016-0198 https://www.futuremedicine.com/doi/pdf/10.2217/pgs-2016-0198 |
| Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|